V-Square Quantitative Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
VPM
VCM
V-Square Quantitative Management's ALNY Position: Q1 2026 in Review
V-Square Quantitative Management increased its Alnylam Pharmaceuticals (ALNY) stake by 0.56% in Q1 2026, buying an estimated $3.74K and bringing the position to 1,969 shares worth $651K. The position accounts for 0.07% of the portfolio, ranked #253.
V-Square Quantitative Management first reported a position in ALNY in Q2 2023 and has held it in 10 quarters since. The position peaked at $779K in Q4 2025. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.
- V-Square Quantitative Management held 1,969 shares of Alnylam Pharmaceuticals worth $651K as of Q1 2026.
- V-Square Quantitative Management bought 11 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $3.74K.
- Alnylam Pharmaceuticals made up 0.07% of V-Square Quantitative Management's portfolio in Q1 2026, its #253 holding.
- V-Square Quantitative Management first reported a position in Alnylam Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
- V-Square Quantitative Management's Alnylam Pharmaceuticals position peaked at $779K in Q4 2025.
- 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.
Based on V-Square Quantitative Management's 13F filing for Q1 2026, filed 27 Apr 2026.